BCAL Diagnostics (ASX:BDX) has taken a major step toward strengthening clinical confidence in its flagship breast cancer diagnostic, announcing national ethics approval for a large-scale registry that will track outcomes for up to 24,000 Australian women. …
BCAL launches national registry to track real-world impact of BREASTESTplus
December 3, 2025 Australian Biotech
Latest Video
New Stories
-
Medtech pipeline accelerates as report showcases translation success of MTPConnect-backed innovators
December 3, 2025 - - Australian Biotech -
CEO pay rebounds across ASX health and biotech as boards balance pressure and retention
December 3, 2025 - - Australian Biotech -
Melbourne scientists discover how electrical pulses could transform tissue and organ regeneration
December 3, 2025 - - Australian Biotech -
Island Pharmaceuticals secures boost as directors and major shareholders exercise options
December 3, 2025 - - Australian Biotech -
BCAL launches national registry to track real-world impact of BREASTESTplus
December 3, 2025 - - Australian Biotech -
Noxopharm advances autoimmune candidate as first multiple-dose cohort clears safety review
December 3, 2025 - - Australian Biotech -
Cost of multiple sclerosis in Australia surges as prevalence accelerates
December 3, 2025 - - Latest News